BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33809707)

  • 1. Reprograming of Tumor-Associated Macrophages in Breast Tumor-Bearing Mice under Chemotherapy by Targeting Heme Oxygenase-1.
    Kim SH; Kim SJ; Park J; Joe Y; Lee SE; Saeidi S; Zhong X; Kim SH; Park SA; Na HK; Chung HT; Surh YJ
    Antioxidants (Basel); 2021 Mar; 10(3):. PubMed ID: 33809707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer cell debris diminishes therapeutic efficacy through heme oxygenase-1-mediated inactivation of M1-like tumor-associated macrophages.
    Kim SH; Saeidi S; Zhong X; Gwak SY; Muna IA; Park SA; Kim SH; Na HK; Joe Y; Chung HT; Kim KE; Han W; Surh YJ
    Neoplasia; 2020 Nov; 22(11):606-616. PubMed ID: 33039895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Role of Heme Oxygenase-1 in the Resolution of Experimentally Induced Colitis through Regulation of Macrophage Polarization.
    Gwak SY; Kim SJ; Park J; Kim SH; Joe Y; Lee HN; Kim W; Muna IA; Na HK; Chung HT; Surh YJ
    Gut Liver; 2022 Mar; 16(2):246-258. PubMed ID: 34737242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Streptococcus virulence protein PepO triggers anti-tumor immune responses by reprograming tumor-associated macrophages in a mouse triple negative breast cancer model.
    Liu B; Huang J; Xiao J; Xu W; Zhang H; Yuan Y; Yin Y; Zhang X
    Cell Biosci; 2023 Nov; 13(1):198. PubMed ID: 37925462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of caveolin-1 scaffolding domain peptides on heme oxygenase-1 activity increasing and M1/M2 phenotype polarization in rat alveolar macrophages induced by lipopolysaccharide].
    Hong K; Yu Z; Sun X; Wu C; Weng P; Wei M; Zuo J; Chen J; Pang Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Sep; 30(9):855-860. PubMed ID: 30309411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer.
    Esser AK; Ross MH; Fontana F; Su X; Gabay A; Fox GC; Xu Y; Xiang J; Schmieder AH; Yang X; Cui G; Scott M; Achilefu S; Chauhan J; Fletcher S; Lanza GM; Weilbaecher KN
    Theranostics; 2020; 10(17):7510-7526. PubMed ID: 32685002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of tumor growth and alteration of associated macrophage cell type by an HO-1 inhibitor in breast carcinoma-bearing mice.
    Deng R; Wang SM; Yin T; Ye TH; Shen GB; Li L; Zhao JY; Sang YX; Duan XG; Wei YQ
    Oncol Res; 2013; 20(10):473-82. PubMed ID: 24308158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonlinear response to cancer nanotherapy due to macrophage interactions revealed by mathematical modeling and evaluated in a murine model via CRISPR-modulated macrophage polarization.
    Leonard F; Curtis LT; Hamed AR; Zhang C; Chau E; Sieving D; Godin B; Frieboes HB
    Cancer Immunol Immunother; 2020 May; 69(5):731-744. PubMed ID: 32036448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage Polarization Contributes to the Anti-Tumoral Efficacy of Mesoporous Nanovectors Loaded with Albumin-Bound Paclitaxel.
    Leonard F; Curtis LT; Ware MJ; Nosrat T; Liu X; Yokoi K; Frieboes HB; Godin B
    Front Immunol; 2017; 8():693. PubMed ID: 28670313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plinabulin, a Distinct Microtubule-Targeting Chemotherapy, Promotes M1-Like Macrophage Polarization and Anti-tumor Immunity.
    Natoli M; Herzig P; Pishali Bejestani E; Buchi M; Ritschard R; Lloyd GK; Mohanlal R; Tonra JR; Huang L; Heinzelmann V; Trüb M; Zippelius A; Kashyap AS
    Front Oncol; 2021; 11():644608. PubMed ID: 33747968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absent in melanoma 2-mediating M1 macrophages facilitate tumor rejection in renal carcinoma.
    Chai D; Zhang Z; Shi SY; Qiu D; Zhang C; Wang G; Fang L; Li H; Tian H; Li H; Zheng J
    Transl Oncol; 2021 Apr; 14(4):101018. PubMed ID: 33493800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heme oxygenase-1 mediates the anti-inflammatory effect of molecular hydrogen in LPS-stimulated RAW 264.7 macrophages.
    Chen HG; Xie KL; Han HZ; Wang WN; Liu DQ; Wang GL; Yu YH
    Int J Surg; 2013; 11(10):1060-6. PubMed ID: 24148794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid HO-1 modulates macrophage polarization and protects against ischemia-reperfusion injury.
    Zhang M; Nakamura K; Kageyama S; Lawal AO; Gong KW; Bhetraratana M; Fujii T; Sulaiman D; Hirao H; Bolisetty S; Kupiec-Weglinski JW; Araujo JA
    JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Propargyl Caffeamide Skews Macrophages Towards a Resolving M2-Like Phenotype Against Myocardial Ischemic Injury via Activating Nrf2/HO-1 Pathway and Inhibiting NF-ĸB Pathway.
    Cheng Y; Yang C; Luo D; Li X; Le XC; Rong J
    Cell Physiol Biochem; 2018; 47(6):2544-2557. PubMed ID: 29996121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M2 tumor-associated macrophages resist to oxidative stress through heme oxygenase-1 in the colorectal cancer tumor microenvironment.
    Ito M; Mimura K; Nakajima S; Okayama H; Saito K; Nakajima T; Kikuchi T; Onozawa H; Fujita S; Sakamoto W; Saito M; Momma T; Saze Z; Kono K
    Cancer Immunol Immunother; 2023 Jul; 72(7):2233-2244. PubMed ID: 36869896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heme oxygenase-2 deletion impairs macrophage function: implication in wound healing.
    Bellner L; Marrazzo G; van Rooijen N; Dunn MW; Abraham NG; Schwartzman ML
    FASEB J; 2015 Jan; 29(1):105-15. PubMed ID: 25342128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage-reprogramming upconverting nanoparticles for enhanced TAM-mediated antitumor therapy of hypoxic breast cancer.
    Yoon J; Le XT; Kim J; Lee H; Nguyen NT; Lee WT; Lee ES; Oh KT; Choi HG; Youn YS
    J Control Release; 2023 Aug; 360():482-495. PubMed ID: 37423526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delicaflavone reactivates anti-tumor immune responses by abrogating monocytic myeloid cell-mediated immunosuppression.
    Li L; You W; Wang X; Zou Y; Yao H; Lan H; Lin X; Zhang Q; Chen B
    Phytomedicine; 2023 Jan; 108():154508. PubMed ID: 36332384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma.
    Jarosz-Biej M; Kamińska N; Matuszczak S; Cichoń T; Pamuła-Piłat J; Czapla J; Smolarczyk R; Skwarzyńska D; Kulik K; Szala S
    PLoS One; 2018; 13(1):e0191012. PubMed ID: 29320562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.